Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Orion Health launches Amadeus CORE to help healthcare sector leverage data analytics and machine learning


A HIPAA compliant and HITRUST certified health data store built on Amazon Web Services for health organizations of all sizes

BOSTON, Oct. 15, 2018 /PRNewswire/ -- Orion Health today announced Amadeus CORE, the latest in its suite of data management, storage and sharing solutions to enable healthcare organizations to take a first step in their data journey towards harnessing the power of big data.

With vast amounts of data from multiple sources to contend with, healthcare organizations struggle to deal with the complicated and expensive technology options for storing large volumes of data securely.

A secure health data store, Amadeus CORE is hosted on Amazon Web Services (AWS) to provide the scalability to support organizations of any size. With HIPAA compliance and HITRUST certification, Amadeus CORE provides a platform for data analytics, machine learning, value-based care and population health management.

Health data can be drawn upon for analysis allowing organizations the flexibility of leveraging the potential of big data now or in the future when the organization is ready to use machine learning models to gain insights and make predictions that could improve the lives of their patients.

"Amadeus CORE helps healthcare organizations prepare for the opportunities that lie ahead in data analytics," said Ian McCrae, Founder and CEO, Orion Health. "Healthcare organizations the world over struggle with disparate and siloed information but see the value of extracting insights from their data for better decision making and more efficient management and operation. Securely storing and enabling access to these vast volumes of health data is the first step in a data journey that healthcare organizations can take to share and unleash the potential of their data."

Preparation is the best medicine

Making the shift to big data, machine learning and artificial intelligence is something 42% of professionals believe will happen in the next three-to-five years but despite these expectations, many are struggling to come to grips with how to leverage big data and the AI capabilities that come with it, Deloitte's 2018 Global Human Capital Trends research recently found.

The analysis highlights a "readiness gap" where 72% see AI as important but only a third of those surveyed felt ready to address it. This is especially the case in healthcare where big data is something that's been spoken about for many years but the reality of the journey to achieving the benefits of what a connected data ecosystem offers has only been achieved by a few.

"Health determinants, in isolation, are interesting. In combination, they're powerful," McCrae said. "Storing and aggregating vast volumes of different data and surfacing it via data analytics and machine learning models brings healthcare organizations a step closer to realizing precision medicine, which is only possible when we have the complete picture of a person's health."

Amadeus CORE has been designed as a platform to handle vast volumes of data from multiple sources and enable machine learning. Its rapid data model development and secure deployment enables users to deliver robust cloud hosted solutions quickly.

Solution highlights

For more information: Orion Health Amadeus CORE Datasheet

About Orion Health

Orion Health (NZX:OHE) is a global health technology company that provides solutions which enable healthcare to more than 100 million patients globally. Built on an open platform, Orion Health is a leading provider of interoperability, population health management and precision medicine solutions. The company employs more than 800 people around the world and is committed to continual innovation, investing substantially in research and development to cement its position at the forefront of precision medicine. For more information visit?www.orionhealth.com

SOURCE Orion Health


These press releases may also interest you

at 16:45
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Alecensa® (alectinib) for adjuvant treatment following tumor resection for patients with anaplastic...

at 16:45
Geron Corporation , a late-stage clinical biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 243,000 shares of Geron common stock as inducements to newly hired employees in connection...

at 16:35
DermTech, Inc. (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today announced that the special committee of its board of directors engaged TD Cowen to conduct a process exploring...

at 16:33
A bill named in memory of four-year-old Ana Lucía "Lulu" Haynes, who passed away from sepsis in 2014, has been reintroduced in the House of Representatives. It arrives ahead of next week's Pediatric Sepsis Week observance, which provides an annual...

at 16:30
Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced it will be presenting promising new preclinical data from its platform built (or optimized) to discover...

at 16:30
BioVaxys Technology Corp. (FRA: 5LB) (the "Company") is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the "MCTO"), by its principal regulator, the Ontario Securities Commission (the...



News published on and distributed by: